ArticleBMC medical genomics2026
A novel homozygous splicing variant in FREM1 expands the phenotypic spectrum of BNAR syndrome: functional validation and successful PGT-M.
Article in BMC medical genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundBifid nose with or without anorectal and renal anomalies (BNAR) is a rare autosomal recessive genetic congenital disorder characterized by bifid nose and renal agenesis, with or without anorectal malformations. Our research identified the genetic factors associated with BNAR in a Chinese pedigree.
methodsMuscle tissue specimens from the fetus and peripheral blood specimens from the parents were collected, and genomic DNA was extracted for whole-exome sequencing. Sanger sequencing was used to verify the emergence of variants in the pedigree. Minigene assays and structural modeling were performed to confirm the influence of intronic variants on mRNA splicing.
resultsWe identified a homozygous splicing variant, c.3274 + 4 A > G, in the FREM1 gene in the fetus. Sanger sequencing revealed that the parents were heterozygous. In vitro and in intro minigene assays revealed exon 18 skipping, causing a nonframeshift, 62 amino acid deletion in FREM1. Structural predictions indicate the deletion severely disrupts the FREM1 CSPG6 domain, replacing its stable interwoven β-sheet architecture with a single β-sheet and an aberrant α-helix. This profound conformational shift likely abolishes the interaction interfaces required for FRAS1/FREM multiprotein complex assembly, impairing its overall function. Based on these findings, the variant was categorized as likely pathogenic according to the American College of Medical Genetics and Genomics guidelines. Accordingly, after being informed about the hazards of the pathogenic variant, the couple selected preimplantation genetic tests for monogenic disorders (PGT-M) and had a healthy baby.
conclusionThis study presents a Chinese fetus with FREM1-related pathology. Moreover, this study extends the phenotypic spectrum of BNAR, while laying a foundation for PGT-M.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.